Publications by authors named "Amanda Jung"

Article Synopsis
  • The study aims to evaluate current knowledge on breast lymphedema (BL) diagnosis and treatment post-breast-conserving surgery, identify gaps, and suggest future research directions.
  • A literature review covering studies from 2000 to 2023 found variations in BL incidence and risk factors, with promising diagnostic methods like tissue dielectric constant and ultrasound, but lacking standardized criteria and strong treatment evidence.
  • The authors conclude that more comprehensive studies are needed to clarify BL’s natural history and improve screening, diagnostic approaches, and treatment guidelines for patients.
View Article and Find Full Text PDF

Background: Increased HIV testing is essential to ending the HIV epidemic. People who inject drugs (PWID) are among the highest risk for HIV infection. Previous research at Tufts Medical Center identified low HIV testing rates in hospitalized PWID.

View Article and Find Full Text PDF
Article Synopsis
  • Lymph node swelling is a notable side effect of mRNA COVID-19 vaccines, especially concerning for women with a history of breast cancer.
  • A survey was sent to nearly 5,000 women treated for breast cancer, with 621 participants reporting their experiences after receiving the vaccine.
  • Common side effects included injection site soreness and fatigue, with most lasting less than 48 hours, while lymph node swelling typically occurred on the vaccine side and lasted about a week.
View Article and Find Full Text PDF

Cycle threshold (Ct), or the number of cycles required to amplify viral RNA to a detectable level, provides an estimate of viral load. Previous studies have demonstrated mixed results in regard to the association between SARS-CoV-2 Ct from real-time reverse transcriptase PCR (rRT-PCR) testing to patient outcomes, and there is less data on the relationship between Ct and patient characteristics. This was a retrospective study of 256 patients tested at a tertiary care emergency department from March to July 2020 via nasopharyngeal rRT-PCR testing utilizing the Abbott M2000 SARS-CoV-2 assay.

View Article and Find Full Text PDF